[HTML][HTML] An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
…, E Martinez-Diaz, E Pimentel-Vazquez… - New …, 2022 - Elsevier
Developing affordable and easily manufactured SARS-CoV-2 vaccines will be essential to
achieve worldwide vaccine coverage and long-term control of the COVID-19 pandemic. Here …
achieve worldwide vaccine coverage and long-term control of the COVID-19 pandemic. Here …
[HTML][HTML] Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome
…, H Pérez-Saad, E Pimentel-Vázquez… - BioMed research …, 2017 - hindawi.com
Soon after epidermal growth factor (EGF) discovery, some in vivo models appeared demonstrating
its property to enhance cutaneous wound healing. EGF was the first growth factor (GF…
its property to enhance cutaneous wound healing. EGF was the first growth factor (GF…
[HTML][HTML] A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein …
…, E Pimentel-Vázquez… - The Lancet Regional …, 2023 - thelancet.com
Background The pandemic of COVID-19 raised the urgent need for safe and efficacious
vaccines against SARS-CoV-2. We evaluated the efficacy and safety of a new SARS-CoV-2 …
vaccines against SARS-CoV-2. We evaluated the efficacy and safety of a new SARS-CoV-2 …
[HTML][HTML] Plant regeneration from leaf and stem explants from two sweet potato(Ipomoea batatas L. Lam.) cultivars
RG Gonzalez, DS Sánchez… - Biotecnologia …, 1999 - tspace.library.utoronto.ca
An efficient protocol for organogenic regeneration of two sweet potato (Ipomoea batatas L.)
elite cultivars, was developed. Several growth regulator combinations and explant sources …
elite cultivars, was developed. Several growth regulator combinations and explant sources …
Very small size proteoliposomes (VSSP) and Montanide combination enhance the humoral immuno response in a GnRH based vaccine directed to prostate cancer
FF Aguilar, JJ Barranco, EB Fuentes, LC Aguilera… - Vaccine, 2012 - Elsevier
Very small size proteoliposomes (VSSP) constitute a complex of very small size proteoliposomes
that includes proteins, lipids, CpG and gangliosides tumor-associated that provides a …
that includes proteins, lipids, CpG and gangliosides tumor-associated that provides a …
Sanitary Registration of Heberprot-P®, an innovative biotechnological medicine for the treatment of diabetic foot ulcers
AR Silva, YQ Maya, EL Mola, MP Molina… - Revista Cubana de …, 2021 - medigraphic.com
Introduction: Heberprot-P® obtained its first Sanitary Registration in Cuba in 2006, and it is
currently approved in 26 other countries. Objective: Describe the sanitary registration process …
currently approved in 26 other countries. Objective: Describe the sanitary registration process …
[HTML][HTML] Minibioreactor-gas collector for determining bacteria-produced hydrogen sulfide
A Hernández García, E Pimentel Vázquez… - Electronic Journal of …, 2003 - SciELO Chile
A simple and economical minibioreactor-gas collector system for determination of hydrogen
sulfide produced by a microorganism was designed. The detection of hydrogen sulfide was …
sulfide produced by a microorganism was designed. The detection of hydrogen sulfide was …
Registro sanitario de Heberprot-P®, medicamento biotecnológico innovador para el tratamiento de las úlceras del pie diabético
AR Silva, YQ Maya, EL Mola, MP Molina… - Revista Cubana de …, 2021 - medigraphic.com
Introducción: Heberprot-P® obtuvo su primer registro sanitario en Cuba en el año 2006,
actualmente está aprobado en otros 26 países. Objetivo: Describir el proceso de registro …
actualmente está aprobado en otros 26 países. Objetivo: Describir el proceso de registro …
Catalizadores enzimá ticos novedosos para la producción de fructooligosacá ridos a partir del azúcar de caña
R Enrique, AM Lasa, RRà Ibañez… - Anales de la …, 2021 - revistaccuba.sld.cu
Introducción: Los fructooligosacáridos (FOS) son fibras solubles con acción prebiótica en
Seres humanos y animales. En la actualidad se comercializan FOS tipo inulina (enlaces …
Seres humanos y animales. En la actualidad se comercializan FOS tipo inulina (enlaces …
The influence of different peptide combinations to increase the immunogenicity of the Gonadotrophin Releasing Hormone Vaccine for prostate cancer treatment.
FF Aguilar, JJ Barranco… - Journal of …, 2017 - search.ebscohost.com
Therapeutic vaccines, specifically the Gonadotrophin Releasing Hormone (GnRH) vaccine,
are considered an additional therapeutic option for advanced stage prostate cancer. Our …
are considered an additional therapeutic option for advanced stage prostate cancer. Our …